TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Race Oncology Ltd. ( (AU:RAC) ).
Race Oncology Ltd has announced the quotation of 493,195 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of October 23, 2025. This move is part of the company’s strategy to enhance its market presence and provide additional value to its stakeholders, potentially impacting its operational capabilities and industry positioning positively.
More about Race Oncology Ltd.
Race Oncology Ltd is a company operating in the biotechnology industry, focusing on the development and commercialization of cancer therapies. The company is known for its innovative approaches to oncology treatments, aiming to address unmet medical needs in the market.
Average Trading Volume: 455,792
Technical Sentiment Signal: Buy
Current Market Cap: A$724M
For detailed information about RAC stock, go to TipRanks’ Stock Analysis page.